Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy

Journal of the Neurological Sciences

Volumn 231, Issue 1-2, 2005, Pages 85-88

  Tsukaguchi, Masago ^a   Shimamura, Mieko ^a   Ikeda, Kazuyo ^a   Urai, Yoshiteru ^a   Sasaki, Iwao ^a   Deguchi, Kazushi ^a   Touge, Tetsuo ^a   Takeuchi, Hiroaki ^b   Kuriyama, Shigeki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Corticosteroids; Invasive thymoma; Low dose tacrolimus; Myasthenia gravis; Thymectomy

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; TACROLIMUS;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CASE REPORT; DRUG DOSE REDUCTION; HELPER CELL; HUMAN; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RELAPSE; REMISSION; T LYMPHOCYTE ACTIVATION; THYMECTOMY; THYMOMA;

EID: 15944421281     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.12.010     Document Type: Article

References (14)

1. D.P. Richman, and M.A. Agius Treatment of autoimmune myasthenia gravis Neurology 61 2003 1652 1661
2. R.M. Pascuzzi, H.B. Coslett, and T.R. Johns Long-term crticosteroid treatment of myasthenia gravis: report of 116 patients Ann. Neurol. 15 1984 291 298
3. J. Palace, J. Newsom-Davis, and B. Lecky A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group Neurology 50 1998 1778 1783
4. R.S. Tindall, J.T. Phillips, J.A. Rollins, L. Wells, and K. Hall A clinical thrapeutic trial of cyclosporine in myasthenia gravis Ann. N. Y. Acad. Sci. 681 1993 539 551
5. T. Kino, H. Hatanaka, S. Miyata, N. Inamura, M. Nishiyama, and T. Yajima FK-506, a novel immunosuppressant isolated from a Streptomyces II. Immunosupressive effect of FK-506 in vitro J. Antibiot. 40 1987 1256 1265
6. U.A. Besinger, K.V. Toyka, M. Hömberg, K. Heininger, R. Hohlfeld, and A. Fateh-Moghadam Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcoline receptors with changes in disease severity Neurology 33 1983 1316 1321
7. A. Masaoka, Y. Monden, K. Nakahara, and T. Tanioka Follow-up study of thymomas with special reference to their clinical stages Cancer 48 1981 2485 2492
8. H. Yoshikawa, K. Iwasa, K. Satoh, M. Takamori, and M. Yamada FK506 prevents induction of rat experimental autoimmune myasthenia gravis J. Autoimmun. 10 1997 11 16
9. T. Konishi, Y. Yoshiyama, M. Takamori, K. Yagi, E. Mukai, and T. Saida Clinical study of FK506 in patients with myasthenia gravis Muscle Nerve 28 2003 570 574
10. M. Alessiani, U. Cillo, J.J. Fung, W. Irish, K. Abu-Elmagd, and A. Jain Adverse effects of FK 506 overdosage after liver transplantation Transplant. Proc. 25 1993 628 634
11. H. Yoshikawa, K. Mabuchi, Y. Yasukawa, M. Takamori, and M. Yamada Low-dose tacrolimus for intractable myasthenia gravis J. Clin. Neurosci. 9 2002 627 628
12. A. Evoli, C.D. Schino, F. Marsili, and C. Punzi Successful treatment of myasthenia gravis with tacrolimus Muscle Nerve 25 2002 111 114
13. M. Tsukaguchi, H. Takeuchi, I. Sasaki, K. Deguchi, and T. Touge Two cases of intractable myasthenia gravis with invasive thymoma in which tacrolimus effectively controlled fluctuation of symptoms Neurol. Ther. 21 2004 83 86
14. K. Utsugisawa, Y. Nagane, H. Yonezawa, D. Obara, R. Kondoh, and H. Tohgi Effects of FK506 on myasthenia gravis with high interleukin-2 productivity in peripheral blood mononuclear cells Muscle Nerve 27 2003 245 248